This inventor holds 1 USPTO granted patent. Top assignee: China Medical University Hospital. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Da-Chuan Cheng: Innovator in Deep Learning for Cancer Detection
Introduction
Da-Chuan Cheng is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical technology, particularly in the area of cancer detection through advanced neural network systems. His innovative work aims to improve the accuracy and efficiency of identifying prostate cancer bone metastasis.
Latest Patents
Da-Chuan Cheng holds a patent for a "System of deep learning neural network in prostate cancer bone metastasis identification based on whole body bone scan images." This system includes a pre-processing module that receives input whole body bone scan images and a neural network module that detects the presence of prostate cancer bone metastasis. The neural network module consists of two key components: a chest portion network module and a pelvis portion network module. The chest portion network establishes a first stage faster R-CNN to segment training images of the chest, while the pelvis portion network categorizes whether the images indicate bone metastasis.
Career Highlights
Cheng is affiliated with China Medical University Hospital, where he applies his expertise in deep learning and medical imaging. His work is pivotal in enhancing diagnostic processes for prostate cancer, ultimately contributing to better patient outcomes.
Collaborations
Cheng collaborates with notable colleagues, including Chia-Chuan Liu and Chia-Hung Kao, who share his commitment to advancing medical technology and improving cancer detection methods.
Conclusion
Da-Chuan Cheng's innovative contributions to deep learning and cancer detection exemplify the potential of technology in transforming healthcare. His work not only advances medical imaging but also holds promise for improving the lives of patients diagnosed with prostate cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile